510(k) K170264
K170264 is an FDA 510(k) premarket notification submitted by Changsha Sinocare, Inc. for the device "Gold AQ Blood Glucose Monitoring System". The FDA issued a decision of Substantially Equivalent on Oct 5, 2017. The device falls under product code NBW (System, Test, Blood Glucose, Over The Counter), a Class II device regulated under 21 CFR 862.1345.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 5, 2017
- Date Received
- Jan 27, 2017
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Blood Glucose, Over The Counter
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type
- 510(k)